Nextgen Biomed Ltd (NXGN)
Nov 10, 2023 - NXGN was delisted (reason: acquired by Thoma Bravo)
23.94
+0.03 (0.13%)
Inactive · Last trade price on Nov 8, 2023

NextGen Healthcare Statistics

Total Valuation

NXGN has a market cap or net worth of $1.97 million. The enterprise value is $1.99 million.

Market Cap 1.97M
Enterprise Value 1.99M

Important Dates

The next confirmed earnings date is Thursday, May 29, 2025, after market close.

Earnings Date May 29, 2025
Ex-Dividend Date n/a

Share Statistics

NXGN has 11.54 million shares outstanding. The number of shares has increased by 15.90% in one year.

Current Share Class n/a
Shares Outstanding 11.54M
Shares Change (YoY) +15.90%
Shares Change (QoQ) +20.30%
Owned by Insiders (%) 15.55%
Owned by Institutions (%) n/a
Float 9.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 2.12
PB Ratio -2.91
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.48
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -3.35

Financial Position

The company has a current ratio of 0.08

Current Ratio 0.08
Quick Ratio 0.05
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.10
Interest Coverage -203.13

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -728.92%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 207.54%
Revenue Per Employee n/a
Profits Per Employee -$447,702
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NXGN has paid $5.53 million in taxes.

Income Tax 5.53M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +18.52% in the last 52 weeks. The beta is 1.14, so NXGN's price volatility has been higher than the market average.

Beta (5Y) 1.14
52-Week Price Change +18.52%
50-Day Moving Average 23.51
200-Day Moving Average 18.67
Relative Strength Index (RSI) 82.49
Average Volume (20 Days) 837,374

Short Selling Information

The latest short interest is 4.84 million, so 7.21% of the outstanding shares have been sold short.

Short Interest 4.84M
Short Previous Month 5.10M
Short % of Shares Out 7.21%
Short % of Float 8.85%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.34M
Pretax Income -1.34M
Net Income -1.34M
EBITDA -1.31M
EBIT -1.34M
Earnings Per Share (EPS) -$0.16
Full Income Statement

Balance Sheet

The company has $9,609 in cash and $60,950 in debt, giving a net cash position of -$51,341 or -$0.00 per share.

Cash & Cash Equivalents 9,609
Total Debt 60,950
Net Cash -51,341
Net Cash Per Share -$0.00
Equity (Book Value) -676,770
Book Value Per Share -0.06
Working Capital -739,917
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$566,126 and capital expenditures -$28,004, giving a free cash flow of -$594,130.

Operating Cash Flow -566,126
Capital Expenditures -28,004
Free Cash Flow -594,130
FCF Per Share -$0.05
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NXGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.90%
Shareholder Yield -15.90%
Earnings Yield -68.11%
FCF Yield -30.13%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference -8.19%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 7.94%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 3, 2023. It was a reverse split with a ratio of 0.1666666667.

Last Split Date Sep 3, 2023
Split Type Reverse
Split Ratio 0.1666666667

Scores

Altman Z-Score n/a
Piotroski F-Score 2